Haemonetics
298 hedge funds and large institutions have $5.74B invested in Haemonetics in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 101 increasing their positions, 104 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
298
Holders Change
+23
Holders Change %
+8.36%
% of All Funds
5.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
53
Increased
101
Reduced
104
Closed
24
Calls
$2.04M
Puts
$230K
Net Calls
+$1.81M
Net Calls Change
+$6M
Top Buyers
| 1 |
Neuberger Berman Group
New York
|
$300M |
| 2 |
Morgan Stanley
New York
|
$46M |
| 3 |
HM
HealthCor Management
New York
|
$61.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$244M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
$20.1M |
